The insurance provider has committed $100m to the Life Science Impact Program, which is managed by Grove Street Advisors and will focus on healthcare businesses.

Japan-based insurer Nippon Life Insurance has committed approximately $100m to the Life Science Impact Program, a healthcare impact fund managed by affiliates of private equity and venture capital investor Grove Street Advisors, DealStreetAsia reported yesterday.

Nippon Life will provide the cash through an unnamed fund managed by its Nissay Asset Management subsidiary. Grove Street does not appear to have disclosed any other limited partners for the fund and it is unclear whether Nippon is expected to be the sole sponsor.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).